The Walt Disney Company on the acquisition of NFL Network and certain other media assets owned and controlled by the NFL, including RedZone Channel and NFL Fantasy, in exchange for a 10% equity stake in ESPN
Zebra Technologies Corp. (Nasdaq: ZBRA) in its $1.3 billion acquisition of Elo, a provider of touchscreens and software solutions, from Crestview Partners
Vista Equity Partners in its investment in AKUVO, a provider of collections and credit risk management software solutions
Avidity Biosciences (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, in its pending $12 billion sale to Novartis AG (NYSE: NVS), and the related spin-off of its early-stage precision cardiology programs
Amicus Therapeutics (Nasdaq: FOLD), a biotechnology company, in its pending $4.8 billion sale to BioMarin Pharmaceutical (Nasdaq: BMRN)
